E.coli Partnering 2007-2012 by bharatbookseo

VIEWS: 7 PAGES: 3

More Info
									E.coli Partnering 2007-2012

Bharatbook.com included a new report on "E.coli Partnering 2007-2012"provides understanding
and access to the e-coli partnering deals and agreements entered into by the worlds leading
healthcare companies.

Trends in e-coli partnering deals
Top e-coli deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The E-coli Partnering 2007-2012 provides understanding and access to the e-coli partnering
deals and agreements entered into by the worlds leading healthcare companies.
http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/ecoli-
partnering-2007-2012.html

The report provides an analysis of e-coli partnering deals. The majority of deals are discovery or
development stage whereby the licensee obtains a right or an option right to license the licensors
e-coli technology. These deals tend to be multicomponent, starting with collaborative R&D, and
commercialization of outcomes.

Understanding the flexibility of a prospective partner?s negotiated deals terms provides critical
insight into the negotiation process in terms of what you can expect to achieve during the
negotiation of terms. Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are triggered ? contract documents
provide this insight where press releases do not.

This data driven report contains over 30 links to online copies of actual e-coli deals and contract
documents as submitted to the Securities Exchange Commission by companies and their
partners, where available. Contract documents provide the answers to numerous questions about
a prospective partner?s flexibility on a wide range of important issues, many of which will have
a significant impact on each party?s ability to derive value from the deal.

The initial chapters of this report provide an orientation of e-coli partnering trends.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the
trends in e-coli partnering since 2007, including a summary of deals by industry sector, stage of
development, deal type, and technology type. Numerous tables provide outline financial trends.

Chapter 3 provides an overview of the leading e-coli deals since 2007. Deals are listed by
headline value, signed by bigpharma, most active bigpharma. Where the deal has an agreement
contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive directory of e-coli partnering deals signed and announced
since 2007. The chapter is organized by company A-Z, stage of development at signing, deal
type (collaborative R&D, co-promotion, licensing etc), and technology type. Each deal title links
via Weblink to an online version of the deal record, and where available the contract document,
providing easy access to each contract document on demand.

In conclusion, this report provides everything a prospective dealmaker needs to know about
partnering in the
research, development and commercialization of e-coli technologies and products.

Report scope
E-coli Partnering 2007-2012 is intended to provide the reader with an in-depth understanding
and access to e-coli trends and structure of deals entered into by leading companies worldwide.

This data driven report includes:
Trends in e-coli dealmaking in the biopharma industry since 2007
Access to summary headline, upfront, milestone and royalty data
The leading e-coli deals by value since 2007

In E-coli Partnering 2007-2012, the available deals are listed by:
Headline value
Upfront payment value
Royalty rate value
Company A-Z
Industry sector
Stage of development at signing
Deal component type
Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the
contract document, providing easy access to each contract document on demand.

For more information kindly visit : http://www.bharatbook.com/market-research-
reports/healthcare-market-research-report/ecoli-partnering-2007-2012.html

Or

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/BharatBook
Our Blogs: http://in.linkedin.com/pub/bharat-book/3a/98/512
http://financemarketreports.blogspot.com/

Bacteria,Heathcare,Pharmaceutical,Market Research Reports

Bharat Book Bureau, the leading market research information aggregator provides market
research reports, company profiles, country reports, newsletters, and online databases for the past
twenty four years to corporate, consulting firms, academic institutions, government departments,
agencies etc., globally, including India. Our market research reports help global companies to
know different market before starting up business / expanding in different countries across the
world.

								
To top